SciSight Ecosystem
WoS SCIE Q2Scopus Q1SCImago #6,318CAS 3区Gold OA

Cancer Nanotechnology

Abbreviation (ISO):CANCER NANOTECHNOL
Country: Austria•WoS SCIE Quartile: Q2•Scopus SJR: 0.849•SCImago Rank: #6,318•Identifier (ISSN):1868-6958(Print)/1868-6966(Online)•Articles / Year: 33•Estimated Publication Fee (APC): $3,208 USD
Clarivate IF (2026)Q2
5.8
↑ +1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
46

46 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate4.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
33articles/year
100% Gold OA•95.35% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 5.8)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.8)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.8)
🔵 Computed
20242.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.5)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.7)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 7.917)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.095)
🔵 Computed
20202.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.7)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Aim: Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas. Scope: Articles describing original research in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer (open submission process). Review, editorial and tutorial articles picking up on subthemes of emerging importance where nanostructures and the induction of nanoscale processes are used for the prevention, diagnosis and treatment of cancer.

Topics Covered (Recognized by AI)
Biology91.5%Medicine86.2%Chemistry85.1%Genetics84%Materials science80.9%Physics76.1%Nanotechnology73.9%Internal medicine73.4%Engineering70.2%Biochemistry68.6%Quantum mechanics66%Chemical engineering60.6%Organic chemistry58.5%Nanoparticle55.9%Cancer52.7%In vitro37.8%Cancer research36.7%Pharmacology29.3%Surgery28.2%Apoptosis28.2%Cancer cell26.6%Drug delivery25.5%Optics25%Cell24.5%Cell culture23.4%Psychology23.4%Biophysics23.4%

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,318Scopus Q1SCImago Profile
Scopus Coverage:2010-2026
Scopus Broad Areas:ChemistryEngineeringMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
0.849

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
46

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
6.25

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,208 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,065
3-Year Documents181
Citable Documents181

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1
Physical and Theoretical ChemistryQ1
Biomedical EngineeringQ2
OncologyQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
Springer Vienna
Publication Language
English
Frequency
Periodic
Founding Year
2010
Editorial Address
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
Indexing & Databases
SCIEScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
NANOSCIENCE & NANOTECHNOLOGY
JCRSCIE
57/148Q2
ONCOLOGY
JCRSCIE
67/333Q1
NANOSCIENCE & NANOTECHNOLOGY
JCISCIE
45/148Q2
ONCOLOGY
JCISCIE
102/333Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—6821
20254.857373
20244.562807
20235.7851,397
20227.91756753
20215.095341,050
20204.715474
2019—11769
2018—11608
2017—10760
2016—11793
2015—4116
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Cancer Nanotechnology

WoS Q2
358102020202120222023202420254.80
Annual Impact Factor Metric
2025:4.8

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 58c1dc43-2d87-47ba-90ad-dacfd0e9a526
Database Updated: 2026-10-01